Defining Tumor Infiltrating B Cells and Their Role in the Modulation of TIL Immunotherapy 2022 ASPIRE Award Shari Pilon-Thomas, PhD; Daniel Abate-Daga, PhD, H. Lee Moffitt Cancer Center and Research Institute; Yong-Chen Lu, PhD, University of Arkansas for Medical Sciences Read More
Reprograming Regulatory T Cells for Cancer Immunotherapy 2022 ASPIRE Award Xiongbin Lu, PhD, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Comprehensive Cancer Center, USA Read More
Targeting SCLC Plasticity with Constellation Pharmacology 2022 ASPIRE Award Trudy Oliver, PhD; Baldomero Olivera, PhD, Huntsman Cancer Institute at the University of Utah Read More
Targeting Androgen Receptor Condensates in Castration Resistant Prostate Cancer 2022 ASPIRE Award; 2024 ASPIRE II Award Denes Hnisz, PhD, Max Planck Institute for Molecular Genetics (Germany) and Xavier Salvatella, PhD, Institute for Research in Biomedicine (IRB Barcelona) Read More
Modeling HBV-Associated Liver Cancer with Hepatocyte Organoids 2022 ASPIRE Award Hans Clevers, MD, PhD, Hubrecht Institute (Netherlands) Read More
A Proof-of-Concept Clinical Trial of an Innovative New Therapy for Glioblastoma 2022 ASPIRE Award Douglas Hanahan, PhD, Ludwig Institute for Cancer Research Lausanne and the Swiss Federal Institute of Technology Lausanne (EPFL) and Andreas Hottinger, MD, PhD, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland, Switzerland Read More